2021
DOI: 10.1055/s-0040-1722198
|View full text |Cite
|
Sign up to set email alerts
|

Looking Back on 2020, Looking Forward to 2021

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
5
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
3

Relationship

3
0

Authors

Journals

citations
Cited by 3 publications
(5 citation statements)
references
References 9 publications
0
5
0
Order By: Relevance
“…We introduced “Accepted manuscripts” in our last year Editorial. 1 T&H has indeed been pleased to offer authors and readers the possibility to publish and read manuscripts almost upon acceptance. The new scheme has been very welcome as shown by the high numbers of authors who chose it upon submission.…”
Section: What's New?mentioning
confidence: 99%
See 1 more Smart Citation
“…We introduced “Accepted manuscripts” in our last year Editorial. 1 T&H has indeed been pleased to offer authors and readers the possibility to publish and read manuscripts almost upon acceptance. The new scheme has been very welcome as shown by the high numbers of authors who chose it upon submission.…”
Section: What's New?mentioning
confidence: 99%
“…At the same time last year we were very much hoping that the extraordinary research and clinical efforts deployed in response to the pandemic outbreak would mean that we would have stepped out of the rollercoaster wagon this year. 1 But here we are in early 2022: the roller coaster elevating again ready for the next vertical plunge. On this ride, however, we came over unprecedented challenges and worldwide scientific collaboration towards vaccine development was accomplished at a speed and efficiency never imaginable so far.…”
mentioning
confidence: 98%
“…As with our traditional new year's message, we aim to summarize our journey in the last year and look forward to 2023. [1][2][3][4] Another year has quickly passed, and as we emerge into more (three-dimensional) in-person meetings rather than the two-dimensional virtual meetings of various platforms, the journal also continues to grow.…”
mentioning
confidence: 99%
“…As with our traditional new year's message, we aim to summarize our journey in the last year and look forward to 2023. 1 2 3 4…”
mentioning
confidence: 99%
“…As in the precedent year, the 2021 COVID-19 pandemic situation has dictated the pace and direction of our research and clinical management efforts which, although not exclusively, is well reflected by this years' Editor's Choice contents. [1][2][3][4] At the end of 2020, we published a Theme Issue dedicated to COVID-19 as a guide to better comprehend newly identified vascular and inflammatory mechanistic aspects of the disease, 5 its hypercoagulation state, 6 and clinical implications for vascular patients with COVID-19. 7,8 To address the rapidly evolving situation and following a first consensus paper, 9 we were pleased to publish an interesting discussion manuscript by the VAS investigators on the need for a more integrated and global strategy to COVID-19, providing a useful overview of public health approaches consideration and the next steps necessary to best manage the pandemic.…”
mentioning
confidence: 99%